drugset / Trial / NCT05461508

Fucoidan Assisted Eradication of Helicobacter Pylori

NCT05461508

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate whether the eradication rate of H.pylori will be improved when adding fucoidan to the duplex scheme combination of amoxicillin and vonoprazan, and to explore the effect of fucoidan on gastrointestinal flora of patients.

Timeline

Start
2022-10-01
Primary completion
2024-06-01
Completion
2024-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fucoidan Unknown 1000 mg
Background Amoxicillin Other / unclassified 1000 mg
Background Vonoprazan Other / unclassified 20 mg